Ausgabe 2/2021
Inhalt (15 Artikel)
Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?
Tasnim Abdalla, Michelle A. Lowes, Nirmal Kaur, Robert G. Micheletti, A. Hillary Steinhart, Afsaneh Alavi
The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses
Aditya K. Gupta, Helen J. Renaud, Emma M. Quinlan, Neil H. Shear, Vincent Piguet
Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review
Hayley Smith, Alison M. Layton, Diane Thiboutot, Abbey Smith, Heather Whitehouse, Waseem Ghumra, Meenakshi Verma, Jerry Tan, Georgina Jones, Kathryn Gilliland, Megha Patel, Elaine Otchere, Anne Eady
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
Kevin Yang, Allen S. W. Oak, Boni E. Elewski
Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity Detection
Courtney E. Heron, Rima I. Ghamrawi, Esther A. Balogh, Steven R. Feldman
The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World
Claire M. Felmingham, Nikki R. Adler, Zongyuan Ge, Rachael L. Morton, Monika Janda, Victoria J. Mar
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial
Elaine C. Siegfried, Thomas Bieber, Eric L. Simpson, Amy S. Paller, Lisa A. Beck, Mark Boguniewicz, Lynda C. Schneider, Faisal A. Khokhar, Zhen Chen, Randy Prescilla, Paola Mina-Osorio, Ashish Bansal
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum
Lawrence F. Eichenfield, Elaine Siegfried, Pearl Kwong, Mark McBride, Jayson Rieger, David Glover, Cynthia Willson, Matthew Davidson, Patrick Burnett, Melissa Olivadoti
Isotretinoin and Risk of Cardiovascular Events in Adults with Acne: A Population-based Retrospective Cohort Study
Serena Ghanshani, Cheng Chen, Bryan Lin, Hui Zhou, Ming-Sum Lee
Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series
Tasnim Abdalla, Mark Mansour, Dorra Bouazzi, Michelle A. Lowes, Gregor B. E. Jemec, Afsaneh Alavi
Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 Patients
Laurent Misery, Jason Shourick, Julien Sénéschal, Carle Paul, Gérard de Pouvourville, Denis Jullien, Emmanuel Mahé, Hervé Bachelez, Roberte Aubert, Pascal Joly, Stéphane Héas, Ziad Reguiai, Khaled Ezzedine, Charles Taieb, Marie-Aleth Richard
Laser-Induced Chrysiasis: A Unique Adverse Event Associated With Q-Switched Lasers
Philip R. Cohen, E. Victor Ross
Reply to: Cohen and Ross: “Laser-Induced Chrysiasis: A Unique Adverse Event Associated with Q-Switched Lasers”
Tina S. Alster, Monica K. Li